ALLO 329 First Clinical Dataset in Autoimmune Disease

Allogene disclosed first-in-human Phase 1 RESOLUTION data for its CD19/CD70 allogeneic CAR T therapy. Skin scores improved in eight of ten assessed systemic sclerosis patients, including recipients without chemotherapy lymphodepletion. The small, uncontrolled, dose-escalating…







